Impaired hepatic function tests after thrombolysis for acute myocardial infarction. 1991

D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
Heart Institute, Sheba Medical Center, Tel Hashomer, Israel.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies

Related Publications

D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
May 1997, Lancet (London, England),
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
December 1994, Postgraduate medicine,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
January 1997, Journal of accident & emergency medicine,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
March 1989, The American journal of cardiology,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
January 2005, Emergency medicine journal : EMJ,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
June 1998, Postgraduate medical journal,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
March 2005, Annales francaises d'anesthesie et de reanimation,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
April 2001, American heart journal,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
March 1990, Journal of the Royal Society of Medicine,
D Freimark, and R Leor, and H Hod, and D Elian, and E Kaplinsky, and B Rabinowitz
April 1998, Circulation,
Copied contents to your clipboard!